Total Payments
$1.3M
2024 Payments
$302,337
Companies
41
Transactions
2,338
Medicare Patients
2,237
Medicare Billing
$701,451
Payment Breakdown by Category
Other$1.0M (77.4%)
Travel$205,352 (15.4%)
Consulting$50,293 (3.8%)
Food & Beverage$41,181 (3.1%)
Research$4,515 (0.3%)
Education$36.41 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.0M | 464 | 77.3% |
| Travel and Lodging | $205,352 | 689 | 15.4% |
| Consulting Fee | $50,293 | 21 | 3.8% |
| Food and Beverage | $41,181 | 1,156 | 3.1% |
| Unspecified | $4,515 | 4 | 0.3% |
| Honoraria | $1,290 | 1 | 0.1% |
| Education | $36.41 | 3 | 0.0% |
Payments by Type
General
$1.3M
2,334 transactions
Research
$4,515
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $340,562 | 625 | $0 (2020) |
| PFIZER INC. | $269,466 | 434 | $0 (2024) |
| ABBVIE INC. | $238,289 | 477 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $179,071 | 155 | $0 (2024) |
| Janssen Biotech, Inc. | $114,004 | 126 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $77,323 | 94 | $0 (2024) |
| Lilly USA, LLC | $62,967 | 82 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $24,537 | 26 | $0 (2022) |
| Celgene Corporation | $9,589 | 71 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $6,775 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $302,337 | 395 | Phathom Pharmaceuticals, Inc. ($77,323) |
| 2023 | $156,585 | 245 | AbbVie Inc. ($65,710) |
| 2022 | $174,588 | 276 | E.R. Squibb & Sons, L.L.C. ($99,623) |
| 2021 | $87,850 | 153 | E.R. Squibb & Sons, L.L.C. ($67,068) |
| 2020 | $45,476 | 91 | AbbVie Inc. ($21,639) |
| 2019 | $217,678 | 463 | PFIZER INC. ($124,066) |
| 2018 | $214,711 | 437 | Allergan Inc. ($155,991) |
| 2017 | $132,746 | 278 | Allergan Inc. ($131,726) |
All Payment Transactions
2,338 individual payment records from CMS Open Payments — Page 1 of 94
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | PFIZER INC. | VELSIPITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $675.00 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: Immunology | ||||||
| 12/19/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $22.35 | General |
| Category: GI | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $322.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $115.85 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | Cash or cash equivalent | $23.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $0.45 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/16/2024 | Lilly USA, LLC | OMVOH (Drug) | Travel and Lodging | Cash or cash equivalent | $253.26 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | Cash or cash equivalent | $134.18 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $95.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | Cash or cash equivalent | $94.09 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Rare Disease | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.37 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,200.00 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Lilly USA, LLC | OMVOH (Drug) | Travel and Lodging | Cash or cash equivalent | $273.36 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | Cash or cash equivalent | $40.43 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Lilly USA, LLC | OMVOH (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Immunology | ||||||
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $1,747.85 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL, PLACEBO-CONTROLLED INDUCTION STUDY OF MIRIKIZUMAB IN CONVENTIONAL-FAILED AND BIOLOGIC-FAILED PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (LUCENT 1) | Eli Lilly and Company | $3,992 | 3 |
| A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-ARM, PLACEBO-CONTROLLED MAINTENANCE STUDY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (LUCENT 2) | Eli Lilly and Company | $522.53 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 583 | 593 | $663,663 | $190,567 |
| 2022 | 11 | 518 | 531 | $582,161 | $169,874 |
| 2021 | 12 | 601 | 613 | $600,111 | $179,486 |
| 2020 | 12 | 535 | 549 | $558,820 | $161,524 |
Total Patients
2,237
Total Services
2,286
Medicare Billing
$701,451
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 139 | 140 | $175,000 | $53,381 | 30.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2023 | 136 | 136 | $156,400 | $45,060 | 28.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Office | 2023 | 30 | 36 | $82,800 | $30,570 | 36.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2023 | 54 | 54 | $62,100 | $17,950 | 28.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 58 | 58 | $63,800 | $14,212 | 22.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 35 | 37 | $42,550 | $8,068 | 19.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 21 | 22 | $25,300 | $6,142 | 24.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 18 | 18 | $12,600 | $3,957 | 31.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 19 | 19 | $17,830 | $3,742 | 21.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $6,656 | $1,932 | 29.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 11 | 11 | $10,016 | $1,795 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 18 | $3,150 | $1,530 | 48.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $2,160 | $1,265 | 58.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $3,301 | $963.17 | 29.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Office | 2022 | 37 | 43 | $98,900 | $39,389 | 39.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 103 | 105 | $131,250 | $39,114 | 29.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2022 | 97 | 97 | $111,550 | $33,858 | 30.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 60 | 64 | $70,400 | $16,007 | 22.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2022 | 40 | 40 | $46,000 | $13,936 | 30.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 29 | 29 | $33,350 | $7,517 | 22.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 17 | 18 | $20,700 | $4,980 | 24.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 14 | 14 | $10,800 | $3,200 | 29.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 15 | 15 | $17,333 | $2,995 | 17.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 18 | 18 | $17,744 | $2,651 | 14.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 30 | $3,600 | $1,566 | 43.5% |
About Dr. Larry Clark, M.D
Dr. Larry Clark, M.D is a Gastroenterology healthcare provider based in Lynchburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780659508.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Larry Clark, M.D has received a total of $1.3M in payments from pharmaceutical and medical device companies, with $302,337 received in 2024. These payments were reported across 2,338 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.0M).
As a Medicare-enrolled provider, Clark has provided services to 2,237 Medicare beneficiaries, totaling 2,286 services with total Medicare billing of $701,451. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Lynchburg, VA
- Active Since 02/23/2006
- Last Updated 07/16/2010
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1780659508
Products in Payments
- LINZESS (Drug) $331,682
- XELJANZ (Drug) $189,058
- ZEPOSIA (Drug) $179,312
- RINVOQ (Biological) $87,345
- VOQUEZNA (Drug) $77,323
- TREMFYA (Drug) $76,160
- VELSIPITY (Drug) $67,345
- STELARA (Biological) $62,348
- SKYRIZI (Biological) $61,274
- OMVOH (Drug) $45,854
- HUMIRA (Biological) $16,459
- VIBERZI (Drug) $12,822
- Humira (Biological) $6,620
- Entyvio (Biological) $6,540
- INFLECTRA (Biological) $4,273
- Linzess (Drug) $829.22
- Ozanimod (Drug) $437.54
- ZENPEP (Drug) $284.34
- DUPIXENT (Biological) $240.11
- Cimzia (Drug) $232.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lynchburg
Mr. Wei Hou, M.d., Ph.d, M.D., PH.D
Gastroenterology — Payments: $7,735
Gastroenterology $7,735
Ralph Wisniewski, M.d, M.D
Gastroenterology — Payments: $6,349
Gastroenterology $6,349
Robert Richards, M.d, M.D
Gastroenterology — Payments: $4,516
Gastroenterology $4,516
Loretta Maffei, M.d, M.D
Gastroenterology — Payments: $2,537
Gastroenterology $2,537
James Curtiss, Md, MD
Gastroenterology — Payments: $350.87
Gastroenterology $350.87
Charles Catalano, M.d, M.D
Gastroenterology — Payments: $70.52
Gastroenterology $70.52